MYRIAD GENETICS INC (MYGN:NASDAQ)
$5.09 0.09 (1.8%)
Analysed MYRIAD GENETICS INC (MYGN:NASDAQ) News Sources
Tempus AI Expands Strategic Partnership Amid Oncology Boom
16-04-2026
yahoo.com
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
16-04-2026
yahoo.com
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
14-04-2026
yahoo.com
1 Cash-Burning Stock to Target This Week and 2 We Question
13-04-2026
yahoo.com
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
09-04-2026
yahoo.com
Myriad Genetics And 2 Other Penny Stocks To Watch Closely
06-04-2026
yahoo.com
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
06-04-2026
yahoo.com
3 Healthcare Stocks with Open Questions
02-04-2026
yahoo.com
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook?
01-04-2026
yahoo.com
Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?
01-04-2026
yahoo.com
What is the current price of MYRIAD GENETICS INC (MYGN:NASDAQ)?
The current price of MYRIAD GENETICS INC (MYGN:NASDAQ) is $5.09.
MYRIAD GENETICS INC (MYGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of MYRIAD GENETICS INC (MYGN:NASDAQ) since the previous trading day is $0.09.
MYRIAD GENETICS INC (MYGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of MYRIAD GENETICS INC (MYGN:NASDAQ) since the previous trading day is 1.8%.
What is the most recent average sentiment score for MYRIAD GENETICS INC (MYGN:NASDAQ)?
The most recent average sentiment score for MYRIAD GENETICS INC (MYGN:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for MYRIAD GENETICS INC (MYGN:NASDAQ)?
The most recent sentiment for MYRIAD GENETICS INC (MYGN:NASDAQ) is .
SEC-8K** Filing Available For MYRIAD GENETICS INC (MYGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.